Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
JERRY S WOLINSKY
Listed Specialty: Neurology
6410 FANNIN ST, 1014, HOUSTON, TX, 77030-3000
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
JERRY WOLINSKY,
Yearly Payment Breakdown:
2018 Payments At a Glance
112
payments
$134,399
payment total
7
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
67 | $95,908 |
Travel and Lodging |
25 | $37,291 |
Food and Beverage |
20 | $1,199 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
OCREVUS |
drug |
$58,989 |
OMB157G |
drug |
$48,782 |
AUBAGIO |
drug |
$20,320 |
Payments with no listed product |
N/A |
$6,150 |
FTD |
drug |
$84 |
REBIF |
drug |
$62 |
OFATUMUMAB |
drug |
$14 |
BAF312A |
drug |
$14 |
FTY720 |
drug |
$12 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Jun 21, 2018 | $11,277 | AUBAGIO | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Nov 15, 2018 | $8,119 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Jul 14, 2018 | $8,084 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Jun 22, 2018 | $7,790 | OMB157G | Consulting | NOVARTIS PHARMA AG | |
| Sep 11, 2018 | $7,790 | OMB157G | Consulting | NOVARTIS PHARMA AG | |
| Apr 24, 2018 | $7,386 | OMB157G | Consulting | NOVARTIS PHARMA AG | |
| Mar 28, 2018 | $6,605 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Jun 21, 2018 | $5,820 | AUBAGIO | Consulting | SANOFI-AVENTIS U.S. LLC | |
| Jun 30, 2018 | $5,506 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| May 4, 2018 | $4,500 | OCREVUS | Consulting | GENENTECH, INC. | |
| Mar 31, 2018 | $3,383 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 21, 2018 | $2,910 | AUBAGIO | Consulting | SANOFI-AVENTIS U.S. LLC | |
| Jan 22, 2018 | $2,870 | No Listed Product | Consulting | ALKERMES, INC. | |
| Jun 30, 2018 | $2,152 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $2,059 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Nov 12, 2018 | $2,050 | No Listed Product | Consulting | ALKERMES, INC. | |
| Jun 30, 2018 | $1,987 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,527 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $1,505 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,473 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,447 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $1,427 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,411 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,393 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,261 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Nov 12, 2018 | $1,230 | No Listed Product | Consulting | ALKERMES, INC. | |
| Nov 13, 2018 | $1,200 | OCREVUS | Consulting | GENENTECH, INC. | |
| Jun 30, 2018 | $1,129 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,129 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $1,118 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $1,059 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $994 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $993 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $941 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $910 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $795 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $795 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $723 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $706 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $663 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $635 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $603 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $603 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $588 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $548 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $548 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $548 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $548 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $494 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $487 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $487 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $482 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $453 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $439 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $438 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $438 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $438 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $438 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $438 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $438 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $408 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Jun 30, 2018 | $398 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $371 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $371 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $365 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $365 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $345 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $314 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Sep 30, 2018 | $314 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 31, 2018 | $311 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Mar 27, 2018 | $303 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Jul 13, 2018 | $303 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Mar 26, 2018 | $303 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Nov 13, 2018 | $303 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Nov 14, 2018 | $303 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Jul 12, 2018 | $303 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| May 4, 2018 | $277 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
| May 4, 2018 | $254 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
| Mar 31, 2018 | $219 | OCREVUS | Consulting | F. HOFFMANN-LA ROCHE AG | |
| May 5, 2018 | $205 | OCREVUS | Food and Beverage | GENENTECH, INC. | |
| Jun 21, 2018 | $156 | AUBAGIO | Food and Beverage | SANOFI-AVENTIS U.S. LLC | |
| Nov 15, 2018 | $126 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Sep 11, 2018 | $122 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Mar 26, 2018 | $94 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| May 4, 2018 | $92 | OCREVUS | Food and Beverage | GENENTECH, INC. | |
| Jun 21, 2018 | $88 | AUBAGIO | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Jul 12, 2018 | $86 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Apr 24, 2018 | $78 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Apr 24, 2018 | $75 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Apr 24, 2018 | $70 | FTD | Food and Beverage | NOVARTIS PHARMA AG | |
| Jun 21, 2018 | $70 | AUBAGIO | Travel and Lodging | SANOFI-AVENTIS U.S. LLC | |
| Sep 11, 2018 | $57 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Nov 13, 2018 | $56 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Nov 14, 2018 | $54 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Jun 22, 2018 | $53 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Mar 25, 2018 | $52 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Nov 12, 2018 | $52 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Nov 12, 2018 | $52 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Jul 11, 2018 | $52 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| Sep 24, 2018 | $52 | REBIF | Food and Beverage | EMD SERONO, INC. | |
| Jun 22, 2018 | $50 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Jul 13, 2018 | $45 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| Mar 27, 2018 | $45 | OMB157G | Food and Beverage | NOVARTIS PHARMA AG | |
| May 4, 2018 | $44 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
| Nov 12, 2018 | $40 | OMB157G | Travel and Lodging | NOVARTIS PHARMA AG | |
| May 4, 2018 | $33 | OCREVUS | Travel and Lodging | GENENTECH, INC. | |
| Apr 24, 2018 | $14 | FTD BAF312A OFATUMUMAB | Food and Beverage | NOVARTIS PHARMA AG | |
| Oct 19, 2018 | $14 | OCREVUS | Food and Beverage | GENENTECH USA, INC. | |
| Oct 10, 2018 | $12 | FTY720 | Food and Beverage | NOVARTIS PHARMA AG | |
| Sep 26, 2018 | $11 | REBIF | Food and Beverage | EMD SERONO, INC. | |
| Oct 19, 2018 | $4 | OCREVUS | Food and Beverage | GENENTECH USA, INC. | |
| Nov 6, 2018 | $4 | OCREVUS | Food and Beverage | GENENTECH USA, INC. |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.